TXNIP and coronary artery disorder: These combined findings indicate that PIK3C2A and TXNIP may play inflammatory roles in the development of CAD and suggest that PIK3C2A may be a novel therapeutic focus in CAD, which requires further studies with the follow-up of involved participants.